Midday movers: Amazon, Pfizer, Pinterest rise; AMD, Starbucks, CVS Health fall

DuPont (DD) PT Raised to $87 at RBC Capital

RBC Capital analyst Arun Viswanathan raised the price target on DuPont (NYSE: DD) to $87.00 (from $83.00) while maintaining a Outperform rating.

The analyst comments "We raise our FY24/25 estimates and price target to $87 given the strong 1Q and raised guidance. We maintain our Outperform rating... More

Deutsche Bank Comments on Block Inc. (SQ)

Deutsche Bank analyst Bryan Keane reiterated a Buy rating and $90.00 price target on Block Inc. (NYSE: SQ)

The analyst comments "SQ yet again reported strong quarterly results with 1Q24 gross profit growth coming in well ahead of expectations at ~22% Y/Y along with $100m+ beats in adj. EBITDA and adj. operating income.... More

Marriott's (MAR) full year guidance upgrade should impress - here's why

Analysts at Bernstein said in a research note Thursday that they believe Marriott (NASDAQ: MAR) full-year guidance should impress.

Marriott reported its first-quarter results today, and while the quarter met Bernstein's expectations, it's the full-year earnings guidance upgrade that's poised to make waves in the... More

Global Payments (GPN) PT Lowered to $155 at Citi

Citi analyst Ashwin Shirvaikar lowered the price target on Global Payments (NYSE: GPN) to $155.00 (from $163.00) while maintaining a Buy rating.

The analyst comments "Global Payments delivered better 1Q margin performance than we anticipated, a key pre-earnings consideration. Revenues also slightly beat via Merchant... More

CDW Corporation (CDW) PT Lowered to $260 at Citi

Citi analyst Asiya Merchant lowered the price target on CDW Corporation (NASDAQ: CDW) to $260.00 (from $295.00) while maintaining a Buy rating.

The analyst comments "CDWs shares -10%, as results missed expectations, and lowered FY2024 guide on 1Q weakness (macro woes, federal push-outs) and expectations of... More

CVS Health (CVS) PT Lowered to $77 at BofA Securities

BofA Securities analyst Michael Cherny lowered the price target on CVS Health (NYSE: CVS) to $77.00 (from $95.00) while maintaining a Buy rating.

The analyst comments "Shares of CVS currently trade at 8x earnings, implying investors have substantial doubt the company can... More

Yum! Brands (YUM) PT Raised to $135 at BMO Capital

BMO Capital analyst Andrew Strelzik raised the price target on Yum! Brands (NYSE: YUM) to $135.00 (from $133.00) while maintaining a Market Perform rating.

The analyst comments "YUMs 1Q24 EPS of $1.15 fell $0.05 below consensus as broadly-softer comps more than offset favorable G&A & taxes.... More

5 analysts weigh in on AMD earnings

AMD (NASDAQ: AMD) reported its latest quarterly earnings after the close Tuesday, with profit in line with consensus expectations and revenue topping estimates.

AMD posted Q1 EPS of $0.62, while revenue for the quarter came in at $5.5 billion versus the consensus estimate of $5.48 billion.

Furthermore, the company sees Q2 2024 revenue of $5.4-6 billion, versus the consensus of $5.7 billion, while for the second quarter of 2024, AMD expects revenue to be approximately $5.7 billion, plus or minus $300 million. At the mid-point of the revenue range, this represents... More